INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GS
Gryaznov SergeiChief Scientific Officer
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
400.0K sh
Apr 10, 2026Apr 14, 2026
Page 972 of 1737
← PrevNext →
traded Apr 10, 2026
+4d
SEC Form 4

Evidence

9
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
28.4K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

9
CJ
Craver JosiahPFO & PAO
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
80.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$838K
1,457 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
RC
Rice CalvinChief Financial Officer & CAO
SPOKSpok Holdings, Inc
Grant or award
A—
0 sh
Apr 14, 2026Apr 14, 2026
traded Apr 14, 2026
+0dSEC Form 4

Evidence

8
RC
Rice CalvinChief Financial Officer & CAO
SPOKSpok Holdings, Inc
Grant or award
A—
0 sh
Apr 14, 2026Apr 14, 2026
traded Apr 14, 2026
+0dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$925K
1,603 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
LB
Lewis BryanDirector, CEO/President
IDNIntellicheck, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
10.0K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$780K
1,354 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

7
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$1.15M
9,593 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

7
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Open-market sale · 10b5-1 plan
SELL$546K
4,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

7
SB
Sevalia Piyush BSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$530K
1,247 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

6
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Option exercise · 10b5-1 plan
M$136K
56.1K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

6
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$4,437
100 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

6
LM
Lo Steve MingChief Accounting Officer
REALTheRealReal, Inc.
Grant or award
A—
31.3K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

5
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
800.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$1,541
253 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$6,052
1,012 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

5
WX
Wan XinChief Technology Officer
GCTGigaCloud Technology Inc
Option exercise
M—
5,500 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$693K
1,210 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

4
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$1,305
130.5K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$347K
601 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$73K
614 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$359K
2,959 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$660K
1,154 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$144K
1,237 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$826K
6,850 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

3
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
16.1K sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

3
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M$236K
1,200 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

2
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Option exercise
M—
7,500 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$65K
600 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$25K
210 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$208K
1,875 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$70K
600 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$178K
1,500 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$160K
281 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$232K
400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$123K
1,100 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$3,847
32 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$57K
500 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence